nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.272	0.446	CbGbCtD
Bupivacaine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.207	0.339	CbGbCtD
Bupivacaine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.132	0.215	CbGbCtD
Bupivacaine—Sensation of heat—Cyclosporine—focal segmental glomerulosclerosis	0.0391	0.1	CcSEcCtD
Bupivacaine—Toxicity to various agents—Cyclosporine—focal segmental glomerulosclerosis	0.0211	0.0543	CcSEcCtD
Bupivacaine—Paresis—Cyclosporine—focal segmental glomerulosclerosis	0.0166	0.0425	CcSEcCtD
Bupivacaine—Stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0159	0.0408	CcSEcCtD
Bupivacaine—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0326	CcSEcCtD
Bupivacaine—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0326	CcSEcCtD
Bupivacaine—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0321	CcSEcCtD
Bupivacaine—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.028	CcSEcCtD
Bupivacaine—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0264	CcSEcCtD
Bupivacaine—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00782	0.0201	CcSEcCtD
Bupivacaine—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.0077	0.0198	CcSEcCtD
Bupivacaine—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.0074	0.019	CcSEcCtD
Bupivacaine—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00693	0.0178	CcSEcCtD
Bupivacaine—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00688	0.0177	CcSEcCtD
Bupivacaine—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00674	0.0173	CcSEcCtD
Bupivacaine—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00594	0.0152	CcSEcCtD
Bupivacaine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00583	0.015	CcSEcCtD
Bupivacaine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00567	0.0146	CcSEcCtD
Bupivacaine—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0049	0.0126	CcSEcCtD
Bupivacaine—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00477	0.0123	CcSEcCtD
Bupivacaine—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00455	0.0117	CcSEcCtD
Bupivacaine—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00453	0.0116	CcSEcCtD
Bupivacaine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00448	0.0115	CcSEcCtD
Bupivacaine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.0113	CcSEcCtD
Bupivacaine—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00411	0.0105	CcSEcCtD
Bupivacaine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00387	0.00993	CcSEcCtD
Bupivacaine—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00382	0.0098	CcSEcCtD
Bupivacaine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00379	0.00973	CcSEcCtD
Bupivacaine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00373	0.00957	CcSEcCtD
Bupivacaine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00369	0.00948	CcSEcCtD
Bupivacaine—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.00868	CcSEcCtD
Bupivacaine—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.00868	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00331	0.00851	CcSEcCtD
Bupivacaine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00329	0.00843	CcSEcCtD
Bupivacaine—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.00827	CcSEcCtD
Bupivacaine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00302	0.00775	CcSEcCtD
Bupivacaine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.00726	CcSEcCtD
Bupivacaine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00282	0.00723	CcSEcCtD
Bupivacaine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.00699	CcSEcCtD
Bupivacaine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.00696	CcSEcCtD
Bupivacaine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00266	0.00682	CcSEcCtD
Bupivacaine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00264	0.00678	CcSEcCtD
Bupivacaine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00668	CcSEcCtD
Bupivacaine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.00665	CcSEcCtD
Bupivacaine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.00659	CcSEcCtD
Bupivacaine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00652	CcSEcCtD
Bupivacaine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00639	CcSEcCtD
Bupivacaine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00635	CcSEcCtD
Bupivacaine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00627	CcSEcCtD
Bupivacaine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.00623	CcSEcCtD
Bupivacaine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.0062	CcSEcCtD
Bupivacaine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.00592	CcSEcCtD
Bupivacaine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00588	CcSEcCtD
Bupivacaine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.00585	CcSEcCtD
Bupivacaine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00577	CcSEcCtD
Bupivacaine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00575	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00573	CcSEcCtD
Bupivacaine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00558	CcSEcCtD
Bupivacaine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00553	CcSEcCtD
Bupivacaine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00553	CcSEcCtD
Bupivacaine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.0055	CcSEcCtD
Bupivacaine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00543	CcSEcCtD
Bupivacaine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.00538	CcSEcCtD
Bupivacaine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00535	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00504	CcSEcCtD
Bupivacaine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00501	CcSEcCtD
Bupivacaine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00497	CcSEcCtD
Bupivacaine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00493	CcSEcCtD
Bupivacaine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00492	CcSEcCtD
Bupivacaine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00487	CcSEcCtD
Bupivacaine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00481	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00478	CcSEcCtD
Bupivacaine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00473	CcSEcCtD
Bupivacaine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00473	CcSEcCtD
Bupivacaine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00456	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00453	CcSEcCtD
Bupivacaine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.0044	CcSEcCtD
Bupivacaine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.00437	CcSEcCtD
Bupivacaine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.00437	CcSEcCtD
Bupivacaine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00408	CcSEcCtD
Bupivacaine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00397	CcSEcCtD
Bupivacaine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00392	CcSEcCtD
Bupivacaine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00379	CcSEcCtD
Bupivacaine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00366	CcSEcCtD
Bupivacaine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00352	CcSEcCtD
Bupivacaine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00347	CcSEcCtD
Bupivacaine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00329	CcSEcCtD
